Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Social inclusion increases with time for zero-tillage wheat in the Eastern Indo-Gangetic PlainsWorld Development.  123. 2019
2019 Sarcopenia & aging in cancerJournal of Geriatric Oncology.  10:374-377. 2019
2019 Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical CenterJournal of the American College of Radiology.  16:315-320. 2019
2019 Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total ResectionInternational Journal of Radiation Oncology - Biology - Physics.  103:453-459. 2019
2019 Incidence of mesorectal node metastasis in locally advanced cervical cancer: its therapeutic implicationsInternational Journal of Gynecological Cancer.  29:48-52. 2019
2019 Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal LymphomaPractical Radiation Oncology2019
2019 Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE)Journal of Geriatric Oncology2019
2019 Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapyJournal of Applied Clinical Medical Physics.  20:17-22. 2019
2019 Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective TrialAdvances in Radiation Oncology.  4:90-95. 2019
2018 How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?Urology.  122:139-146. 2018
2018 Brain dosimetry from locally advanced head and neck cancer radiotherapy: implications for neurocognitive outcomes researchActa Oncologica.  57:1589-1592. 2018
2018 Dynamics of the vaginal wall dose in HDR interstitial brachytherapy for gynecological cancer: Systematic analysis of phantom vs patient caseMedical Dosimetry.  43:237-242. 2018
2017 Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancerUrologic Oncology: Seminars and Original Investigations.  35:663.e15-663.e21. 2017
2017 Fractionated stereotactic radiation therapy for intact brain metastasesAdvances in Radiation Oncology.  2:564-571. 2017
2017 Gait Speed and Survival in Patients With Brain MetastasesJournal of Pain and Symptom Management.  54:105-109. 2017
2017 CT measures of bone mineral density and muscle mass can Be used to predict noncancer death in men with prostate cancerRadiology.  282:475-483. 2017
2017 Distant brain recurrence in patients with five or more newly diagnosed brain metastases treated with focal stereotactic radiotherapy alone.Journal of Radiosurgery and SBRT.  4:255-263. 2017
2016 Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neckJournal of Radiation Oncology.  5:363-369. 2016
2016 Mesorectal node metastasis from gynecological cancer in the era of 3D conformal pelvic radiation therapy and intensity modulated radiation therapyPractical Radiation Oncology.  6:402-404. 2016
2016 Combining Computed Tomography-Based Bone Density Assessment with FRAX Screening in Men with Prostate CancerJournal of Clinical Densitometry.  19:430-435. 2016
2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinomaHPB.  18:843-850. 2016
2016 Evaluating the Role of Urinalysis for Suspected Cystitis in Women Undergoing Pelvic Radiotherapy.International Journal of Gynecological Cancer2016
2016 Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesWorld Journal of Gastroenterology.  22:3006-3014. 2016
2016 Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high-grade prostate adenocarcinomaProstate Cancer.  2016. 2016
2015 Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy AloneJournal of Gastrointestinal Cancer.  46:149-155. 2015
2014 Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: The University of Alabama at Birmingham experienceNeuro Oncology Practice.  1:172-177. 2014
2014 ReplyUrology.  84:1388. 2014
2014 Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapyRadiation Oncology.  9. 2014
2014 An empirical assessment of two-dimensional (2D) Debye-Scherrer-type image-plate X-ray diffraction data collapsed into a 1D diffractogramPowder Diffraction.  29:337-345. 2014
2014 PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalationUrologic Oncology: Seminars and Original Investigations.  32:687-693. 2014
2014 Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapyUrology.  84:1383-1388. 2014
2013 Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancerActa Oncologica.  52:1181-1188. 2013
2013 Patient benefit from salvage radiation for prostate cancer.Journal of Clinical Oncology.  31:175. 2013
2013 Spontaneous spinal epidural abscess presenting in a previously healthy young adult manCase Reports in Medicine.  2013. 2013
2012 Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.Prostate Cancer.  2012:546794. 2012
2011 Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.Journal of Clinical Oncology.  29:85. 2011

Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2012
  • Master of Sciences or Mathematics, University of Alabama at Birmingham 2008
  • Bachelor of Science or Mathematics, University of Alabama at Birmingham 2006
  • Birmingham Baptist Health Systems, Internship 2013
  • University of Alabama at Birmingham, Residency 2017
  • Full Name

  • Andrew McDonald